Tesofensine: Additional Phase II data

NeuroSearch said tesofensine met the primary and the secondary endpoints in the open-label, Danish, Phase II TIPO-4 extension of the double-blind, placebo-controlled, Phase II TIPO-1 trial. Patients r...